BFM 89.9

HIGHLIGHTS 
Podcast  >  Morning Run  >  Morning Brief  >  All About Merck's Molnupiravir Drug

All About Merck's Molnupiravir Drug

Sam Fazeli, Director of Research, Bloomberg Intelligence

11-Oct-21 07:30

All About Merck's Molnupiravir Drug

Last week, Health Minister Khairy Jamaludin said that the government would procure 150,000 treatment packages of a Covid-19 anti-viral drug produced by Merck called Molnupiravir. The drug is being described by many quarters as a gamechanger in the fight against Covid-19. Based on trials conducted so far, the medication was shown to reduce the risk of hospitalization or death by around 50% in patients with mild-to-moderate symptoms of the virus. We get the lowdown on Molnupiravir from Sam Fazeli, Director of Research at Bloomberg Intelligence.

Image credit: Quality Stock Arts / Shutterstock.com

Produced by: Shazana Mokhtar

Presented by: Wong Shou Ning, Philip See, Shazana Mokhtar


This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  Business AnalysisTrends and ForecastsMarketsPoliticsSocial IssuesHealth PolicyDiseases & ConditionsMental HealthHealthy LivingFitnessMedical Innovation and Technologylaw & legal mattersScienceInvestments

Tags:  MerckCovid-19MedicinePandemicVaccinationsGlobal





Play / Pause

Listen now : BFM 89.9 -- The Business Station

Today’s Shows



6:00 AM

The 6AM Stretch

Thought-provoking discussions on ideas, people and events shaping our lives.

7:00 AM

World Market Watch

Tim Mulholland of TJM Limited, Chicago tells us where international markets are heading.

7:15 AM

Morning Brief

We recap global and local headlines from today's papers and portals.

7:30 AM

Morning Brief

Steve Durose of Fitch Ratings weighs in as the firm downgrades its 2025 outlook for the APAC tech sector to ‘deteriorating’.

7:45 AM

Morning Brief

Brendan Sobie, Independent Analyst and Consultant, Sobie Aviation discusses the challenges that low cost carriers are facing.

8:00 AM

The Breakfast Grille

Professor Dr. Barry Winn, Vice Chancellor and President, Taylor's University, discusses trends in K-12 education, parents' expectations and student outcomes, income generation, and more.

8:30 AM

Morning Brief

Dato' Malik Imtiaz Sarwar discusses the silence in regards to the extension of the tenures of Malaysia's top judges.

8:45 AM

Morning Brief

We speak to Sebastian Strangio of The Diplomat about the recent clash at the border of Cambodia and Thailand which has left a soldier dead.

9:00 AM

Opening Bell

Tim Mulholland of TJM Limited, Chicago tells us where international markets are heading.

9:15 AM

Opening Bell

(REPEAT) We take a look at the FBM KLCI as well as regional capital markets.

9:35 AM

What's The Focus

We wrap up the week’s biggest conversations to keep you in the know.

10:05 AM

Open For Business

Mascon Technologies, a Singapore-based Maritime Tech start-up founded in 2022 aims to help digitise, verify and simplify the work done on the ships - quite literally - and in the office. We speak with Mascon’s CEO and Co-Founder, Hakim Sanwan, about their inception story, the challenges of building a tech company in the maritime sector, their ambitions ahead, and how Mascon is positioning itself within a complex and traditional industry.

11:00 AM

Mattsplained

12:00 PM

Enterprise Explores

1:00 PM

The Breakfast Grille Repeat

Professor Dr. Barry Winn, Vice Chancellor and President, Taylor's University, discusses trends in K-12 education, parents' expectations and student outcomes, income generation, and more.

2:05 PM

Discovery Hour

An eclectic selection of BBC shows, curated with variety in mind.

3:05 PM

Front Row

tbc

3:20 PM

Front Row

tbc

4:05 PM

Health & Living

Is there a single test for all the cancers out there? Is there truth to blood tests that claim to test for multiple cancers? We speak to an expert to find out.

5:00 PM

Top 5 at 5

6:00 PM

Popcorn Culture

Reviews of Ballerina and Thug Life, followed by a discussion on gangster films, and their appeal.

7:00 PM

BBC World Service

8:00 PM

Bar None

9:00 PM

The Selector